Harm Reduction for Smokers With Mental Illness
ConditionTobacco Dependence
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorDartmouth-Hitchcock Medical Center
About this trial
To compare the efficacy of e-cigarette (e-cig) provision with or without behavioral support (SWITCH IT) delivered via telehealth to reduce harm among smokers with MI who cannot quit smoking and are not ready to pursue cessation treatment, and to examine self-regulation (using e-cigs instead of cigarettes to cope with stress/distress and self-efficacy) as a potential mechanism for behavior change from SWITCH IT
Eligibility criteria
Qualifiers
Schizophrenia
Bipolar disorder
Major Depressive Disorders
Posttraumatic disorder
Disqualifiers
Currently residing in a nursing home;
Current diagnosis of Asthma;
Cognitive impairment (score <26 on the Telephone Interview for Cognitive Status (TICS);
Current use of e-cigarettes (>once a week);
Trial design
Treatments tested in this trial
- SWITCH IT
- E-cig Provision Only
Treatment groups
250 Participants
are divided into 2 treatment groupsSponsors and collaborators
Dartmouth-Hitchcock Medical Center
Lead sponsor
Dartmouth College
Collaborator
Fordham University
Collaborator
Seven Counties Services
Collaborator
Western Michigan University School of Medicine
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov